Skip to content

Clinical trials

Irritable Bowel Syndrome trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Irritable Bowel Syndrome Country / region: Russia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20141
20161
20171
20182
20211
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Enrolling by invitation1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Menarini Group2
Abbott1
Astellas Pharma Inc1
Celgene1
Center of New Medical Technologies1
Federal Research and Clinical Center of Physical-Chemical Medicine1
Federal Stare Budgetary Scientific Institution, Mental Health Research Center1
Moscow State University of Medicine and Dentistry1
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department1
S.LAB (SOLOWAYS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Irritable Bowel Syndrome12
Crohn Disease3
Colitis, Ulcerative2
Diarrhea2
Intestinal Diseases2
Anxiety Disorders1
Biliary Dyskinesia1
Cholelithiasis1
Gastroesophageal Reflux1
Ichthyosis Bullosa of Siemens1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.